Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal

03-08-2020

Sarah Morgan

Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal

Keitma / Shutterstock.com

The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine. 


Sanofi, GSK, COVID-19, vaccine, COVID-19 vaccine, Operation Warp Speed, US government, Donald Trump, collaboration

LSIPR